CD274 and neoplasm: In addition to the cellular crosstalk, TAMs often express PD-L1 to inhibit phagocytosis and tumor immunity (Gordon et al., 2017), which was a consensual target for ICIs to enhance anti-tumor immunity (Cha et al., 2019).